Organogenesis Holdings (ORGO) Return on Invested Capital (2017 - 2025)

Organogenesis Holdings' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.01% for Q2 2025.

• On a quarterly basis, Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q2 2025; TTM through Jun 2025 was 0.01%, a 0.0% change from a year earlier, with the FY2023 full-year figure at 0.02%, down 6.0% from the prior year.
• Return on Invested Capital rose to 0.01% in Q2 2025 per ORGO's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.07% in Q4 2021 and bottomed at 0.01% in Q1 2025.
• The 5-year median for Return on Invested Capital is 0.01% (2023), against an average of 0.02%.
• Across the five-year window, Return on Invested Capital advanced 6 bps in 2021 and retreated 6 bps in 2022, its largest moves.
• Year by year, Return on Invested Capital stood at 0.07% in 2021, then tumbled by 83 bps to 0.01% in 2022, then plunged by 62 bps to 0.0% in 2023, then tumbled by 96 bps to 0.0% in 2024, then plunged by 5109 bps to 0.01% in 2025.
• Per Business Quant, the three latest ORGO Return on Invested Capital figures stand at 0.01% (Q2 2025), 0.01% (Q1 2025), and 0.0% (Q4 2024).